North America Organ Preservation Market is segmented By Transportation Technique (Static Cold Storage (SCS), Hypothermic Perfusion Preservation (HPP), Normothermic Machine Perfusion, and Others) By Preservation Solution (University of Wisconsin Solution, Custodiol HTK, Perfadex, and Others) By Organ Type (Kidney, Liver, Lung, and Others), and By Region (US, Canada, and Rest of North America) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
North America Organ Preservation Market Overview
The North America Organ Preservation Market is expected to grow at a CAGR of 9% during the forecast period 2023-2030.
Organ transplantation entails removing an organ from a donor body, transferring the organ, and transplanting the organ into another body while protecting the organ from major harm. Although inducing hypothermia by lowering organ temperature may aid in preservation, distinct bodily organs need specific and suitable storage settings to sustain their anatomical and physiological activities.
The growing prevalence of organ failure, increased research and development, technological improvements, and rising chronic renal disease are the primary driving factors projected to fuel market growth.
North America Organ Preservation Market Summary and Scope
|
Metrics |
Details |
|
CAGR |
9% |
|
Size Available for Years |
2021-2030 |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Transportation Technique, Preservation Solution, and Organ Type |
|
Countries Covered |
US, Canada, and Rest of North America |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report Request for Sample
North America Organ Preservation Market Growth Factors
The North American organ preservation demand is on the rise due to rising number of cases of organ failure. In addition, the increasing incidence of organ failure and the growing amount of organ transplant surgeries in North America are driving the market forward.
One of the key factors in Cardiovascular Diseases has become one of the most prevalent causes of death and morbidity during the preceding three decades. Coronary artery disease, arrhythmias, peripheral vascular disease, heart failure, and congenital heart abnormalities are the most prevalent cardiovascular illnesses in North America.
The increased incidence of renal failure and chronic kidney disease is expected to fuel market growth. Furthermore, the rising frequency of chronic liver disease and cirrhosis in North America is likely to drive market growth.
The major growth factors for the organ preservation market are increasing incidences of organ failures occurring globally due to the rapid growth of the senior population, as well as various regional authorities providing favorable regulations, organizing initiatives, and developing awareness programs to increase the volume of organ donations and transplantation procedures in North America.
North America Organ Preservation Market Segmentation Analysis
The North America Organ Preservation Market is segmented by transportation technique, preservation solution, and organ type.
Transportation Technique: The Static Cold Storage Segment is Expected to Grow at the Fastest CAGR During the Forecast Period
The static cold storage (SCS) segment has the largest market share in the North America organ preservation market due to a rise in the number of organ failures, which has led to a growth in organ transplantation and research activities. Static cold storage involves the movement of donated organs on ice. For many decades, it has been the finest standard for the preservation of various organizations.
Static cold storage is based on hypothermia, which reduces the demand for oxygen as well as cellular metabolism, allowing for the preservation of organs to last longer. Cold storage reduces metabolic activity by around tenfold and promotes anaerobic metabolism, which interrupts the energy cycle. According to the nature journal article "Organ Preservation: From Past to Future," static cold storage is the most successful and easy method for organ preservation and transportation. This is the most prevalent strategy for organ preservation.
North America Organ Preservation Market Regional Insights
Based on region, the North America organ preservation market is segmented into US, Canada, and Rest of North America.
Geographically, North America led the Organ Preservation Market with a 39 per cent market share. The increasing use of enhanced medical technology and increased development by organ preservation businesses are prominent factors driving the market throughout the projected period.
North America led the market in 2022 and is projected to do this shortly. The increased acceptance of novel healthcare technologies, the high incidence of chronic renal illness and heart failure, enhanced reimbursement laws, and increased expenditures in healthcare infrastructure are all propelling the industry forward.
North America Organ Preservation Market Competitive Landscape
The key players operating in the North America organ preservation market are Essential Pharmaceuticals, Dr. Franz Kohler Chemie GmbH, Organ Recovery Systems, Xvivo Perfusion AB, and Waters Medical Systems LLC.
